It was reported to boston scientific corporation that a tria ureteral stent was used in a stent placement study procedure for stone management for stones in the right ureter performed on (b)(6) 2022 as part of the u0652 double-j registry clinical study.The subject was pre-stented on (b)(6) 2022 with one stent to the right ureter, which was removed on (b)(6) 2022 in operating room.On (b)(6) 2022, the tria ureteral stent was successfully placed for stone management laser lithotripsy (with or without extraction) in the right ureter.No issues were reported with the device during placement.Discharge medications included alpha blocker, anticholinergic, nsaids, and phenazopyridine.According to the complainant, following the procedure, on (b)(6) 2022, the patient had experienced moderate right flank pain.The patient was given tylenol es, advil dual and oxybutynin to treat the pain.A planned stent removal procedure was performed and the stent was successfully removed without any difficulty.Oral pain control was given to the patient.There were no new device implanted.No issues were noted with the devices during removal.On (b)(6) 2022, the event was considered resolved.
|